| Typicality: | 0.354 |
| Saliency: | 0.283 |
| after preliminary safety tests in adults | 4 | other |
| separately | 2 | manner |
| vaccine → be tested in → child | 12 |
| vaccine → be tested on → child | 9 |
| vaccine → be studied in → child | 3 |
| negative | neutral | positive |
| 0.274 | 0.605 | 0.122 |
| Raw frequency | 24 |
| Normalized frequency | 0.283 |
| Modifier score | 0.450 |
| Perplexity | 44.615 |